DUL:ETR
Alnylam Pharmaceuticals, Inc.
€259.00
arrow_upward
+2.57%(+6.50) 1H
24 Jun, 10:49:18 PG GMT+2 · EUR
search
Semua simbol
1H
5H
1B
6B
TSS
1T
5T
MAKS
| Simbol | Harga | Perubahan | % Perubahan |
|---|
insights_autoMenjana cerapan popular untuk DUL...
Buka
€258.90
Tinggi
€259.00
Rendah
€258.90
Permodalan Pasaran
38.48B
Purata volum
12.00
Volum
15.00
tgi 52 mgu
€417.40
rdh 52 mgu
€239.80
Bilangan pekerja
2K
Buka
€258.90
Tinggi
€259.00
Rendah
€258.90
Permodalan Pasaran
38.48B
Purata volum
12.00
Volum
15.00
tgi 52 mgu
€417.40
rdh 52 mgu
€239.80
Bilangan pekerja
2K
Cerita berita
Daripada sumber merentas web
TipRanks
·
1 jam lalu
Regulatory Rebuke Sends Alnylam Stock into Tailspin
Simply Wall Street
·
2 jam lalu
AI-Driven RNAi Push and Nordic Expansion Might Change The Case For Investing In Alnylam (ALNY)
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Perihal Alnylam Pharmaceuticals, Inc.
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut